Peru

Peru

Peruvian Clinical Trials Registry (REPEC)

Verified on June 24, 2022

Peru has a primary registry, Peruvian Clinical Trials Registry (REPEC) which has a provision to register a clinical trial. REPEC is a World Health Organization (WHO) recognized primary registry. It was developed in 2007 by the National Institute of Health (INS) and contains records of clinical trials since 1995. Information on all clinical trials submitted to the General Office for Research and Technology Transfer (OGITT) by the National Institute of Health (INS) and that has been authorized or not authorized to be executed in Peru is published on it.

Registries at a Glance
Registry PHUSE Categorization Information to be Entered By Route of Data in Registry Study Type Language
REPEC Mandatory National Database (includes Ethics Requirement) Competent authority Clinical Trial Application

Interventional

(Phase 1-4);

Observational

Spanish
English
Registration and Results Requirements
Registry Activity Legal Requirement Timing
REPEC Registration

Yes

Prior to enrollment
Results

Yes

Not yet specified

Registry Updates


References


  1. Regulation of Clinical Trials Approved with Supreme Decree N° 021-2017-SA. Regulation of Clinical Trials. https://ensayosclinicos-repec.ins.gob.pe/images/REC-021-2017-sa-1538902-2.pdf. Published June 30, 2017. Accessed February 1, 2019.